247 related articles for article (PubMed ID: 16928597)
1. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD
Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597
[TBL] [Abstract][Full Text] [Related]
2. Effect of synthetic peptides corresponding to residues 313-332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3.
Mitsios JV; Tambaki AP; Abatzis M; Biris N; Sakarellos-Daitsiotis M; Sakarellos C; Soteriadou K; Goudevenos J; Elisaf M; Tsoukatos D; Tsikaris V; Tselepis AD
Eur J Biochem; 2004 Feb; 271(4):855-62. PubMed ID: 14764102
[TBL] [Abstract][Full Text] [Related]
3. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of peptide inhibitors derived from the extracellular and intracellular domain of α
Gkourogianni AV; Kiouptsi K; Koloka V; Moussis V; Tsikaris V; Bachelot-Loza C; Tsoukatos DC
Platelets; 2018 Jan; 29(1):34-40. PubMed ID: 28351192
[TBL] [Abstract][Full Text] [Related]
6. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
7. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
8. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
9. A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.
Honda S; Tomiyama Y; Shiraga M; Tadokoro S; Takamatsu J; Saito H; Kurata Y; Matsuzawa Y
J Clin Invest; 1998 Sep; 102(6):1183-92. PubMed ID: 9739052
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
11. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
[TBL] [Abstract][Full Text] [Related]
12. AFM imaging of ligand binding to platelet integrin alphaIIbbeta3 receptors reconstituted into planar lipid bilayers.
Hussain MA; Agnihotri A; Siedlecki CA
Langmuir; 2005 Jul; 21(15):6979-86. PubMed ID: 16008412
[TBL] [Abstract][Full Text] [Related]
13. Construction of drug screening cell model and application to new compounds inhibiting FITC-fibrinogen binding to CHO cells expressing human alphaIIbbeta3.
Yang J; Yao J; Chen J; Wang XN; Zhu TY; Chen LL; Chu P
Eur J Pharmacol; 2009 Sep; 618(1-3):1-8. PubMed ID: 19619528
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylated peptide, being derived from the carboxyl-terminal sequence of the integrin αIIb cytoplasmic domain, inhibits talin binding to αIIbβ₃.
Gkourogianni A; Egot M; Koloka V; Moussis V; Tsikaris V; Panou-Pomonis E; Sakarellos-Daitsiotis M; Bachelot-Loza C; Tsoukatos DC
Platelets; 2014; 25(8):619-27. PubMed ID: 24246298
[TBL] [Abstract][Full Text] [Related]
15. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
Afrasiabi A; Gelain F; Artoni A; Mannucci PM
Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
[TBL] [Abstract][Full Text] [Related]
16. Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptide.
Derrick JM; Shattil SJ; Poncz M; Gruppo RA; Gartner TK
Thromb Haemost; 2001 Sep; 86(3):894-901. PubMed ID: 11583324
[TBL] [Abstract][Full Text] [Related]
17. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
[TBL] [Abstract][Full Text] [Related]
18. A palmitoylated peptide, derived from the acidic carboxyl-terminal segment of the integrin alphaIIb cytoplasmic domain, inhibits platelet activation.
Koloka V; Christofidou ED; Vaxevanelis S; Dimitriou AA; Tsikaris V; Tselepis AD; Panou-Pomonis E; Sakarellos-Daitsiotis M; Tsoukatos DC
Platelets; 2008 Nov; 19(7):502-11. PubMed ID: 18979362
[TBL] [Abstract][Full Text] [Related]
19. Human neutrophil elastase proteolytically activates the platelet integrin alphaIIbbeta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain. Involvement in the potentiation of platelet aggregation.
Si-Tahar M; Pidard D; Balloy V; Moniatte M; Kieffer N; Van Dorsselaer A; Chignard M
J Biol Chem; 1997 Apr; 272(17):11636-47. PubMed ID: 9111081
[TBL] [Abstract][Full Text] [Related]
20. Disabled-2 is a novel alphaIIb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation.
Huang CL; Cheng JC; Stern A; Hsieh JT; Liao CH; Tseng CP
J Cell Sci; 2006 Nov; 119(Pt 21):4420-30. PubMed ID: 17074833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
